Beverly Lu

Beverly Lu, PhD, possesses extensive experience in the fields of venture capital and biotechnology, serving as an investor at Yosemite and as a venture capital investor at Emerson Collective. In addition, Beverly holds the position of Director on the Board of Directors at Ten63 Therapeutics and has previously served as a Director at Amgen. Prior to these roles, Beverly worked as an Engagement Manager at McKinsey & Company. Educationally, Beverly Lu earned a Doctor of Philosophy (PhD) in Chemistry from Caltech and also attended Harvard University.